Find Research Outputs

Search results

• 2019

  Assessment of surgical skills by using surgical navigation in robot-assisted partial nephrectomy

  Kobayashi, S., Cho, B., Huaulmé, A., Tatsugami, K., Honda, H., Jannin, P., Hashizumea, M. & Eto, M., Aug 1 2019, In: International Journal of Computer Assisted Radiology and Surgery. 14, 8, p. 1449-1459 11 p.

  Research output: Contribution to journal › Article › peer-review

  • Nephrectomy
  • Navigation
  • Surgeons
  • Robots
  • Robotics
  6 Citations (Scopus)

• Association of Missense Polymorphism in HSD3B1 With Outcomes Among Men With Prostate Cancer Treated With Androgen-Deprivation Therapy or Abiraterone

  Shiota, M., Narita, S., Akamatsu, S., Fujimoto, N., Sumiyoshi, T., Fujiwara, M., Uchiumi, T., Habuchi, T., Ogawa, O. & Eto, M., Feb 1 2019, In: JAMA network open. 2, 2, p. e190115

  Research output: Contribution to journal › Article › peer-review

  Open Access

  • abiraterone
  • Androgens
  • Prostatic Neoplasms
  • Odds Ratio
  • Castration
  15 Citations (Scopus)

• Cancer immunotherapy, challenge to tomorrow

  Eto, M. & Nasu, Y., Jun 2019, In: Nishinihon Journal of Urology. 81, 3, 1 p.

  Research output: Contribution to journal › Article › peer-review

• Cigarette smoking augments androgen receptor activity and promotes resistance to antiandrogen therapy

  Shiota, M., Ushijima, M., Imada, K., Kashiwagi, E., Takeuchi, A., Inokuchi, J., Tatsugami, K., Kajioka, S. & Eto, M., Jul 1 2019, In: Prostate. 79, 10, p. 1147-1155 9 p.

  Research output: Contribution to journal › Article › peer-review

  • Androgen Antagonists
  • Androgen Receptors
  • Cigarette Smoking
  • Prostatic Neoplasms
  • MDV 3100
  3 Citations (Scopus)

• Clinical significance of programmed death-1 and programmed death-ligand 1 expression in the tumor microenvironment of clear cell renal cell carcinoma

  the Japanese Society of Renal Cancer, Jun 2019, In: Cancer Science. 110, 6, p. 1820-1828 9 p.

  Research output: Contribution to journal › Article › peer-review

  Open Access

  • Tumor Microenvironment
  • Renal Cell Carcinoma
  • Ligands
  • Protein-Tyrosine Kinases
  • Vascular Endothelial Growth Factor A
  9 Citations (Scopus)

• Corrigendum to: Perinephric invasion as a prognostic factor in non-metastatic renal cell carcinoma: analysis of a nation-wide registry program

  Kume, H., Homma, Y., Shinohara, N., Obara, W., Kondo, T., Kimura, G., Fujimoto, H., Nonomura, N., Hongo, F., Sugiyama, T., Takahashi, M., Kanayama, H. O., Fukumori, T. & Eto, M., Dec 18 2019, In: Japanese journal of clinical oncology. 49, 11, 1 p.

  Research output: Contribution to journal › Article › peer-review

  Open Access

• Development of robotic urologic surgery in Asia

  Kim, S. D., Sung, G. T., Eto, M., Tatsugami, K., Garg, H., Kumar, R., Sun, Y., Yang, B., Wu, S. T., Chiu, A. W., Ng, A. C. F., Yee, S. C. H., Sim, H. G. & Cheng, C. W. S., Jan 1 2019, Endourology Progress: Technique, Technology and training. Springer Singapore, p. 35-47 13 p.

  Research output: Chapter in Book/Report/Conference proceeding › Chapter

  • Robotics
  • Minimally Invasive Surgical Procedures
  • Urology
  • Costs and Cost Analysis
  • Fees and Charges

• Efficacy and safety of 4-weekly cabazitaxel for castration-resistant prostate cancer: a multi-institutional study

  Shiota, M., Nakamura, M., Yokomizo, A., Tomoda, T., Sakamoto, N., Seki, N., Hasegawa, S., Yunoki, T., Harano, M., Kuroiwa, K. & Eto, M., Sep 1 2019, In: Cancer chemotherapy and pharmacology. 84, 3, p. 561-566 6 p.

  Research output: Contribution to journal › Article › peer-review

  • cabazitaxel
  • Castration
  • Hazards
  • Prostatic Neoplasms
  • Safety
  1 Citation (Scopus)

• Efficacy and safety of cabazitaxel for castration-resistant prostate cancer in patients with > 10 cycles of docetaxel chemotherapy: a multi-institutional study

  Shiota, M., Nakamura, M., Yokomizo, A., Tomoda, T., Sakamoto, N., Seki, N., Hasegawa, S., Yunoki, T., Harano, M., Kuroiwa, K. & Eto, M., Apr 1 2019, In: Medical Oncology. 36, 4, 32.

  Research output: Contribution to journal › Article › peer-review

  • cabazitaxel
  • Docetaxel
  • Castration
  • Prostatic Neoplasms
  • Safety
  4 Citations (Scopus)

• Establishment of precision medicine in pharmacotherapy for castration-resistant prostate cancer

  Shiota, M. & Eto, M., Apr 2019, In: Nishinihon Journal of Urology. 81, 2, p. 155-160 6 p.

  Research output: Contribution to journal › Article › peer-review

  • Precision Medicine
  • Castration
  • Prostatic Neoplasms
  • Drug Therapy
  • Radium-223

• Genetic Polymorphism in Sex Hormone-binding Globulin With a Prognosis of Androgen Deprivation Therapy in Metastatic Prostate Cancer Among Japanese Men

  Shiota, M., Fujimoto, N., Tsukahara, S., Ushijima, M., Takeuchi, A., Kashiwagi, E., Inokuchi, J., Tatsugami, K., Uchiumi, T. & Eto, M., Jun 2019, In: Clinical Genitourinary Cancer. 17, 3, p. e387-e393

  Research output: Contribution to journal › Article › peer-review

  • Sex Hormone-Binding Globulin
  • Genetic Polymorphisms
  • Androgens
  • Prostatic Neoplasms
  • Testosterone
  1 Citation (Scopus)

• How has the treatment outcomes for advanced renal cell carcinomalmproved in the 10 years after approval of targeted therapy ?

  Imada, K. & Eto, M., Jan 2019, In: Japanese Journal of Cancer and Chemotherapy. 46, 1, p. 40-44 5 p.

  Research output: Contribution to journal › Article › peer-review

• IJU this issue

  Eto, M., Jun 1 2019, In: International journal of urology : official journal of the Japanese Urological Association. 26, 6, p. 595 1 p.

  Research output: Contribution to journal › Article › peer-review

  Open Access

• Immune suppression by PD-L2 against spontaneous and treatment-related antitumor immunity

  Tanegashima, T., Togashi, Y., Azuma, K., Kawahara, A., Ideguchi, K., Sugiyama, D., Kinoshita, F., Akiba, J., Kashiwagi, E., Takeuchi, A., Irie, T., Tatsugami, K., Hoshino, T., Eto, M. & Nishikawa, H., Aug 1 2019, In: Clinical Cancer Research. 25, 15, p. 4808-4819 12 p.

  Research output: Contribution to journal › Article › peer-review

  • Immunity
  • Animal Models
  • Neoplasms
  • Renal Cell Carcinoma
  • Squamous Cell Carcinoma
  12 Citations (Scopus)

• Impact of Previous, Simultaneous or Subsequent Bladder Cancer on Prognosis after Radical Nephroureterectomy for Upper Urinary Tract Urothelial Carcinoma

  JCOG UOSG, Dec 1 2019, In: The Journal of urology. 202, 6, p. 1127-1135 9 p.

  Research output: Contribution to journal › Article › peer-review

  • Nephroureterectomy
  • Urinary Tract
  • Urinary Bladder Neoplasms
  • Carcinoma
  • Survival
  5 Citations (Scopus)

• Inhibitory functions of PD-L1 and PD-L2 in the regulation of anti-tumor immunity in murine tumor microenvironment

  Umezu, D., Okada, N., Sakoda, Y., Adachi, K., Ojima, T., Yamaue, H., Eto, M. & Tamada, K., Feb 13 2019, In: Cancer Immunology, Immunotherapy. 68, 2, p. 201-211 11 p.

  Research output: Contribution to journal › Article › peer-review

  • Tumor Microenvironment
  • Immunity
  • Monoclonal Antibodies
  • Neoplasms
  • Programmed Cell Death 1 Ligand 2 Protein
  15 Citations (Scopus)

• Lenvatinib plus everolimus or pembrolizumab versus sunitinib in advanced renal cell carcinoma: Study design and rationale

  Grünwald, V., Powles, T., Choueiri, T. K., Hutson, T. E., Porta, C., Eto, M., Sternberg, C. N., Rha, S. Y., He, C. S., Dutcus, C. E., Smith, A., Dutta, L., Mody, K. & Motzer, R. J., Mar 2019, In: Future Oncology. 15, 9, p. 929-941 13 p.

  Research output: Contribution to journal › Article › peer-review

  Open Access

  • lenvatinib
  • pembrolizumab
  • Sunitinib
  • Everolimus
  • Renal Cell Carcinoma
  13 Citations (Scopus)

• MicroRNA-204-5p: A novel candidate urinary biomarker of Xp11.2 translocation renal cell carcinoma

  Kurahashi, R., Kadomatsu, T., Baba, M., Hara, C., Itoh, H., Miyata, K., Endo, M., Morinaga, J., Terada, K., Araki, K., Eto, M., Schmidt, L. S., Kamba, T., Linehan, W. M. & Oike, Y., Jun 2019, In: Cancer Science. 110, 6, p. 1897-1908 12 p.

  Research output: Contribution to journal › Article › peer-review

  Open Access

  • Renal Cell Carcinoma
  • MicroRNAs
  • Exosomes
  • Biomarkers
  • Transgenic Mice
  11 Citations (Scopus)

• Mirabegron induces relaxant effects via cAMP signaling-dependent and -independent pathways in detrusor smooth muscle

  Maki, T., Kajioka, S., Itsumi, M., Kareman, E., Lee, K., Shiota, M. & Eto, M., Apr 2019, In: LUTS: Lower Urinary Tract Symptoms. 11, 2, p. O209-O217

  Research output: Contribution to journal › Article › peer-review

  • mirabegron
  • Smooth Muscle
  • Swine
  • Carbachol
  • Escin
  3 Citations (Scopus)

• Nivolumab in patients with unresectable locally advanced or metastatic urothelial carcinoma: CheckMate 275 2-year global and Japanese patient population analyses

  Ohyama, C., Kojima, T., Kondo, T., Naya, Y., Inoue, T., Tomita, Y., Eto, M., Hisasue, S., Uemura, H., Obara, W., Kikuchi, E., Sharma, P., Galsky, M. D., Siefker-Radtke, A., Grossfeld, G., Collette, S., Gooden, K. & Kimura, G., Sep 13 2019, In: International Journal of Clinical Oncology. 24, 9, p. 1089-1098 10 p.

  Research output: Contribution to journal › Article › peer-review

  • Nivolumab
  • Carcinoma
  • Advisory Committees
  • Population
  • Confidence Intervals
  5 Citations (Scopus)

• Nivolumab versus everolimus in advanced renal cell carcinoma: Japanese subgroup 3-year follow-up analysis from the Phase III CheckMate 025 study

  Tomita, Y., Fukasawa, S., Shinohara, N., Kitamura, H., Oya, M., Eto, M., Tanabe, K., Saito, M., Kimura, G., Yonese, J., Yao, M. & Uemura, H., May 29 2019, In: Japanese journal of clinical oncology. 49, 6, p. 506-514 9 p.

  Research output: Contribution to journal › Article › peer-review

  • Nivolumab
  • Everolimus
  • Renal Cell Carcinoma
  • Population
  • Confidence Intervals
  15 Citations (Scopus)

• Overview of current and future systemic therapy for metastatic renal cell carcinoma

  Osawa, T., Takeuchi, A., Kojima, T., Shinohara, N., Eto, M. & Nishiyama, H., 2019, In: Japanese journal of clinical oncology. 49, 5, p. 395-403 9 p.

  Research output: Contribution to journal › Article › peer-review

  • Renal Cell Carcinoma
  • Vascular Endothelial Growth Factor A
  • Nivolumab
  • TOR Serine-Threonine Kinases
  • lenvatinib
  11 Citations (Scopus)

• Papillary renal cell carcinoma with massive hematoma mimicking hemangioma

  Hiraki, Y., Okamoto, D., Nishie, A., Asayama, Y., Ishigami, K., Ushijima, Y., Takayama, Y., Fujita, N., Eto, M., Kinoshita, F. & Honda, H., Aug 2019, In: Radiology Case Reports. 14, 8, p. 1003-1006 4 p.

  Research output: Contribution to journal › Article › peer-review

  Open Access

  • Hemangioma
  • Renal Cell Carcinoma
  • Hematoma
  • Hemorrhage
  • Tomography
  1 Citation (Scopus)

• Partial nephrectomy for renal tumors

  Tatsugami, K. & Eto, M., Aug 2019, In: Nishinihon Journal of Urology. 81, 4, p. 435-439 5 p.

  Research output: Contribution to journal › Review article › peer-review

  • Nephrectomy
  • Kidney
  • Neoplasms
  • Nephrons
  • Margins of Excision

• Perinephric invasion as a prognostic factor in non-metastatic renal cell carcinoma: Analysis of a nation-wide registry program

  Kume, H., Homma, Y., Shinohara, N., Obara, W., Kondo, T., Kimura, G., Fujimoto, H., Nonomura, N., Hongo, F., Sugiyama, T., Takahashi, M., Kanayama, H. O., Fukumori, T. & Eto, M., Aug 1 2019, In: Japanese journal of clinical oncology. 49, 8, p. 772-779 8 p.

  Research output: Contribution to journal › Article › peer-review

  Open Access

  • Renal Cell Carcinoma
  • Registries
  • Fats
  • Multivariate Analysis
  • Cohort Studies
  1 Citation (Scopus)

• Predictive factors for residual cancer in second transurethral resection for non-muscle-invasive bladder cancer

  Akitake, M., Yamaguchi, A., Shiota, M., Imada, K., Tatsugami, K., Yokomizo, A., Naito, S. & Eto, M., 2019, In: Anticancer research. 39, 8, p. 4325-4328 4 p.

  Research output: Contribution to journal › Article › peer-review

  • Residual Neoplasm
  • Urinary Bladder Neoplasms
  • Carcinoma in Situ
  • Neoplasm Staging
  2 Citations (Scopus)

• Profile of pembrolizumab in the treatment of patients with unresectable or metastatic urothelial carcinoma

  Inokuchi, J. & Eto, M., 2019, In: Cancer Management and Research. 11, p. 4519-4528 10 p.

  Research output: Contribution to journal › Article › peer-review

  Open Access

  • pembrolizumab
  • Carcinoma
  • Drug Therapy
  • atezolizumab
  • Platinum
  2 Citations (Scopus)

• Prognostic significance of antihypertensive agents in men with castration-resistant prostate cancer

  Shiota, M., Kobayashi, T., Kashiwagi, E., Takeuchi, A., Inokuchi, J., Tatsugami, K. & Eto, M., Nov 2019, In: Urologic Oncology: Seminars and Original Investigations. 37, 11, p. 813.e21-813.e26

  Research output: Contribution to journal › Article › peer-review

  • Castration
  • Antihypertensive Agents
  • Docetaxel
  • Androgen Receptors
  • Prostatic Neoplasms

• Prognostic significance of diabetes mellitus and dyslipidemia in men receiving androgen-deprivation therapy for metastatic prostate cancer

  Hirata, Y., Shiota, M., Kobayashi, T., Kashiwagi, E., Takeuchi, A., Inokuchi, J., Tatsugami, K. & Eto, M., Dec 2019, In: Prostate International. 7, 4, p. 166-170 5 p.

  Research output: Contribution to journal › Article › peer-review

  Open Access

  • Dyslipidemias
  • Androgens
  • Diabetes Mellitus
  • Prostatic Neoplasms
  • Metabolic Diseases
  1 Citation (Scopus)

• Prognostic significance of risk stratification in CHAARTED and LATITUDE studies among Japanese men with de novo metastatic prostate cancer

  Shiota, M., Namitome, R., Kobayashi, T., Inokuchi, J., Tatsugami, K. & Eto, M., Mar 2019, In: International Journal of Urology. 26, 3, p. 426-428 3 p.

  Research output: Contribution to journal › Comment/debate › peer-review
  10 Citations (Scopus)

• Psoas muscle volume is correlated with sexual activity and erectile dysfunction among patients with localised prostate cancer

  Kashiwagi, E., Imada, K., Monji, K., Takeuchi, A., Shiota, M., Inokuchi, J., Tatsugami, K. & Eto, M., Oct 1 2019, In: Andrologia. 51, 9, e13354.

  Research output: Contribution to journal › Article › peer-review

  • Psoas Muscles
  • Erectile Dysfunction
  • Sexual Behavior
  • Prostatic Neoplasms
  • Body Composition

• Reconstitution of the embryonic kidney identifies a donor cell contribution to the renal vasculature upon transplantation

  Murakami, Y., Naganuma, H., Tanigawa, S., Fujimori, T., Eto, M. & Nishinakamura, R., Dec 1 2019, In: Scientific reports. 9, 1, 1172.

  Research output: Contribution to journal › Article › peer-review

  Open Access

  • Transplantation
  • Kidney
  • Endothelial Cells
  • Pluripotent Stem Cells
  • Blood Vessels
  3 Citations (Scopus)

• Serum Prognostic Factors of Androgen-deprivation Therapy among Japanese Men with De Novo Metastatic Prostate Cancer

  Kobayashi, T., Namitome, R., Hirata, Y., Shiota, M., Imada, K., Kashiwagi, E., Takeuchi, A., Inokuchi, J., Tatsugami, K. & Eto, M., 2019, In: Anticancer research. 39, 6, p. 3191-3195 5 p.

  Research output: Contribution to journal › Article › peer-review

  • Androgens
  • Prostatic Neoplasms
  • L-Lactate Dehydrogenase
  • Confidence Intervals
  • Alkaline Phosphatase
  1 Citation (Scopus)

• Serum testosterone level as possible predictive marker in androgen receptor axis-targeting agents and taxane chemotherapies for castration-resistant prostate cancer

  Shiota, M., Kashiwagi, E., Murakami, T., Takeuchi, A., Imada, K., Inokuchi, J., Tatsugami, K. & Eto, M., Mar 2019, In: Urologic Oncology: Seminars and Original Investigations. 37, 3, p. 180.e19-180.e24

  Research output: Contribution to journal › Article › peer-review

  • taxane
  • Castration
  • Androgen Receptors
  • Testosterone
  • Prostatic Neoplasms
  7 Citations (Scopus)

• TFE3 XP11.2 translocation renal cell carcinoma mouse model reveals novel therapeutic targets and identifies GPNMB as a diagnostic marker for human disease

  Baba, M., Furuya, M., Motoshima, T., Lang, M., Funasaki, S., Ma, W., Sun, H. W., Hasumi, H., Huang, Y., Kato, I., Kadomatsu, T., Satou, Y., Morris, N., Karim, B. O., Ileva, L., Kalen, J. D., Krisna, L. A. W., Hasumi, Y., Sugiyama, A., Kurahashi, R. & 12 others, Nishimoto, K., Oyama, M., Nagashima, Y., Kuroda, N., Araki, K., Eto, M., Yao, M., Kamba, T., Suda, T., Oike, Y., Schmidt, L. S. & Marston Linehan, W., Aug 1 2019, In: Molecular Cancer Research. 17, 8, p. 1613-1626 14 p.

  Research output: Contribution to journal › Article › peer-review

  Open Access

  • Renal Cell Carcinoma
  • Therapeutics
  • Biomarkers
  • Kidney
  • N-(4-bromo-2-fluorophenyl)-6-methoxy-7-((1-methylpiperidin-4-yl)methoxy)quinazolin-4-amine
  4 Citations (Scopus)

• The impact of genetic polymorphism on CYP19A1 in androgen-deprivation therapy among Japanese men

  Shiota, M., Fujimoto, N., Tsukahara, S., Ushijima, M., Takeuchi, A., Kashiwagi, E., Inokuchi, J., Tatsugami, K., Uchiumi, T. & Eto, M., Jan 1 2019, In: Cancer chemotherapy and pharmacology.

  Research output: Contribution to journal › Article › peer-review

  • Polymorphism
  • Genetic Polymorphisms
  • Androgens
  • Testosterone
  • Genes
  3 Citations (Scopus)

• Therapeutic outcome of >10 cycles of cabazitaxel for castration-resistant prostate cancer: A Multi-institutional Study

  Shiota, M., Nakamura, M., Yokomizo, A., Tomoda, T., Sakamoto, N., Seki, N., Hasegawa, S., Yunoki, T., Harano, M., Kuroiwa, K. & Eto, M., 2019, In: Anticancer research. 39, 8, p. 4411-4414 4 p.

  Research output: Contribution to journal › Article › peer-review

  • cabazitaxel
  • Castration
  • Prostatic Neoplasms
  • Survival
  • Treatment Failure

• Treatment patterns and outcomes in patients with unresectable or metastatic renal cell carcinoma in Japan

  Harada, K., Nozawa, M., Uemura, M., Tatsugami, K., Osawa, T., Yamana, K., Kimura, G., Fujisawa, M., Nonomura, N., Eto, M., Shinohara, N., Tomita, Y., Kondo, Y., Ochi, K., Anazawa, Y. & Uemura, H., Feb 1 2019, In: International Journal of Urology. 26, 2, p. 202-210 9 p.

  Research output: Contribution to journal › Article › peer-review

  • Renal Cell Carcinoma
  • Japan
  • Protein-Tyrosine Kinases
  • Phosphotransferases
  • Survival
  11 Citations (Scopus)
• 2018

  Advantages and disadvantages of immune-checkpoint inhibitors

  Sugimoto, M. & Etoh, M., Jan 1 2018, In: Japanese Journal of Clinical Urology. 72, 1, p. 42-48 7 p.

  Research output: Contribution to journal › Article › peer-review

• Androgen - Producing adrenocortical adenoma with acromegaly due to growth hormone - Producing pituitary tumor: A case report

  Maehara, R., Imagawa, D., Murakami, Y., Kawano, Y., Yamaguchi, T., Kamba, T. & Eto, M., Dec 2018, In: Nishinihon Journal of Urology. 80, 12, p. 663-668 6 p.

  Research output: Contribution to journal › Article › peer-review

  • Adrenocortical Adenoma
  • Acromegaly
  • Dehydroepiandrosterone
  • Glandular and Epithelial Neoplasms
  • Pituitary Neoplasms

• Axitinib versus placebo as an adjuvant treatment of renal cell carcinoma: Results from the phase III, randomized ATLAS trial

  Gross-Goupil, M., Kwon, T. G., Eto, M., Ye, D., Miyake, H., Seo, S. I., Byun, S. S., Lee, J. L., Master, V., Jin, J., DeBenedetto, R., Linke, R., Casey, M., Rosbrook, B., Lechuga, M., Valota, O., Grande, E. & Quinn, D. I., 2018, In: Annals of Oncology. 29, 12, p. 2371-2378 8 p.

  Research output: Contribution to journal › Article › peer-review

  Open Access

  • Axitinib
  • Renal Cell Carcinoma
  • Disease-Free Survival
  • Advisory Committees
  • Placebos
  53 Citations (Scopus)

• Axitinib vs placebo in patients at high risk of recurrent renal cell carcinoma (RCC): ATLAS trial results

  Gross-Goupil, M., Kwon, T. G., Eto, M., Ye, D., Miyake, H., Seo, S. I., Byun, S. S., Lee, J. L., Master, V., Jin, J., Debenedetto, R., Linke, R., Casey, M., Rosbrook, B., Lechuga Frean, M. J., Valota, O., Grande, E. & Quinn, D. I., Oct 1 2018, In: Annals of oncology : official journal of the European Society for Medical Oncology. 29, p. viii303

  Research output: Contribution to journal › Article › peer-review

  Open Access

• Bladder cancer-associated cancer-testis antigen-derived long peptides encompassing both CTL and promiscuous HLA class II-restricted Th cell epitopes induced CD4⁺ T cells expressing converged T-cell receptor genes in vitro

  Tsuruta, M., Ueda, S., Yew, P. Y., Fukuda, I., Yoshimura, S., Kishi, H., Hamana, H., Hirayama, M., Yatsuda, J., Irie, A., Senju, S., Yuba, E., Kamba, T., Eto, M., Nakayama, H. & Nishimura, Y., Apr 3 2018, In: OncoImmunology. 7, 4, e1415687.

  Research output: Contribution to journal › Article › peer-review

  • T-Cell Receptor Genes
  • T-Lymphocyte Epitopes
  • Testicular Neoplasms
  • 1-(2-(dodecyloxy)ethyl)pyrrolidine hydrochloride
  • Cytotoxic T-Lymphocytes
  5 Citations (Scopus)

• Chemotherapy for metastatic testicular cancer: The first nationwide multi-institutional study by the Cancer Registration Committee of the Japanese Urological Association

  the Cancer Registration Committee of the Japanese Urological Association, Aug 2018, In: International Journal of Urology. 25, 8, p. 730-736 7 p.

  Research output: Contribution to journal › Article › peer-review

  • Testicular Neoplasms
  • Ifosfamide
  • Drug Therapy
  • Cisplatin
  • Etoposide
  3 Citations (Scopus)

• Clinical Outcomes in Patients With Metastatic Papillary Renal-Cell Carcinoma: A Multi-Institutional Study in Japan

  Ito, K., Mikami, S., Tatsugami, K., Masumori, N., Shinohara, N., Kondo, T., Nakanishi, S., Nagashima, Y., Eto, M., Kamba, T., Kuroda, N., Tomita, Y., Matsuyama, H., Onishi, T., Tsushima, T., Nakazawa, H., Oya, M., Ozono, S., Naito, S. & Asano, T., Dec 2018, In: Clinical Genitourinary Cancer. 16, 6, p. e1201-e1214

  Research output: Contribution to journal › Article › peer-review

  • Renal Cell Carcinoma
  • Japan
  • Protein-Tyrosine Kinases
  • Therapeutics
  • Survival
  3 Citations (Scopus)

• Clinicopathological significance and antitumor effect of MPHOSPH1 in testicular germ cell tumor

  Abe, T., Kohashi, K., Takemoto, J., Kinoshita, F., Eto, M. & Oda, Y., 2018, In: Journal of Cancer. 9, 23, p. 4440-4448 9 p.

  Research output: Contribution to journal › Article › peer-review

  • Testicular Germ Cell Tumor
  • Embryonal Carcinoma Stem Cells
  • Seminoma
  • RNA Interference
  • Embryonal Carcinoma
  1 Citation (Scopus)

• Collateral resistance to taxanes in enzalutamide-resistant prostate cancer through aberrant androgen receptor and its variants

  Shiota, M., Dejima, T., Yamamoto, Y., Takeuchi, A., Imada, K., Kashiwagi, E., Inokuchi, J., Tatsugami, K., Kajioka, S., Uchiumi, T. & Eto, M., Oct 2018, In: Cancer Science. 109, 10, p. 3224-3234 11 p.

  Research output: Contribution to journal › Article › peer-review

  • MDV 3100
  • Taxoids
  • Androgen Receptors
  • Prostatic Neoplasms
  • taxane
  8 Citations (Scopus)

• Comparison of the diagnostic efficacy and perioperative outcomes of limited versus extended pelvic lymphadenectomy during robot-assisted radical prostatectomy: a multi-institutional retrospective study in Japan

  Morizane, S., Honda, M., Fukasawa, S., Komaru, A., Inokuchi, J., Eto, M., Shimbo, M., Hattori, K., Kawano, Y. & Takenaka, A., Jun 1 2018, In: International Journal of Clinical Oncology. 23, 3, p. 568-575 8 p.

  Research output: Contribution to journal › Article › peer-review

  • Prostatectomy
  • Lymph Node Excision
  • Japan
  • Retrospective Studies
  • Lymph Nodes
  4 Citations (Scopus)

• Cyclophosphamide-induced tolerance in kidney transplantation avoids long-term immunosuppressive therapy

  Takeuchi, A., Kato, K., Akashi, K. & Eto, M., Feb 1 2018, In: International Journal of Urology. 25, 2, p. 112-120 9 p.

  Research output: Contribution to journal › Review article › peer-review

  • Kidney Transplantation
  • Cyclophosphamide
  • Immunosuppressive Agents
  • Chimerism
  • Transplantation
  4 Citations (Scopus)

• Demographics, management and treatment outcomes of benign and malignant retroperitoneal tumors in Japan

  the Kyushu Cooperative Urological Research Group, Jan 2018, In: International Journal of Urology. 25, 1, p. 61-67 7 p.

  Research output: Contribution to journal › Article › peer-review

  • Japan
  • Demography
  • Neoplasms
  • Survival
  • Liposarcoma
  8 Citations (Scopus)